Financial Gravity Asset Management, Inc. Amarin Corp Plcuk Transaction History

Financial Gravity Asset Management, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.82 - $1.35 $154 - $253	188 New	188 $167,000
Q2 2023 Aug 08, 2023	SELL	$1.12 - $1.49 $1 - $1	-1 Reduced 50.0%	1 $1.06 Million
Q1 2023 May 12, 2023	BUY	$1.19 - $2.19 $1 - $2	1 Added 100.0%	2 $345,000
Q4 2022 Feb 15, 2023	BUY	$1.07 - $1.34 $1 - $1	1 New	1 $0
Q2 2021 Aug 11, 2021	SELL	$4.26 - $6.5 $8 - $13	-2 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.03 - $8.8 $45 - $79	-9 Reduced 81.82%	2 $13,000
Q4 2020 Feb 16, 2021	BUY	$4.04 - $5.31 $44 - $58	11 New	11 $0
Q1 2020 May 12, 2020	SELL	$4.0 - $21.53 $16,276 - $87,605	-4,069 Closed	0 $0
Q4 2019 Feb 28, 2020	BUY	$13.94 - $24.12 $56,596 - $97,927	4,060 Added 45111.11%	4,069 $21,000
Q3 2019 Oct 15, 2019	SELL	$13.89 - $23.16 $13,584 - $22,650	-978 Reduced 99.09%	9 $0
Q2 2019 Jul 26, 2019	SELL	$16.27 - $20.51 $3,075 - $3,876	-189 Reduced 16.07%	987 $19,000
Q1 2019 Apr 19, 2019	BUY	$12.61 - $22.33 $14,829 - $26,260	1,176 New	1,176 $24,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.